insulin glargine/lixisenatide fixed-ratio combination (LixiLan)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for insulin glargine/lixisenatide fixed-ratio combination (LixiLan), covering 2020-06-16 to 2020-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan [Phase 3]